✦ LIBER ✦

A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

✍ Scribed by Paik, Paul K.; Rudin, Charles M.; Pietanza, Maria C.; Brown, Andrew; Rizvi, Naiyer A.; Takebe, Naoko; Travis, William; James, Leonard; Ginsberg, Michelle S.; Juergens, Rosalyn; Markus, Susan; Tyson, Leslie; Subzwari, Sara; Kris, Mark G.; Krug, Lee M.

Book ID: 119320616
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 201 KB
Volume: 74
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2011.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of obatoclax mesylate, a

A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

✍ Paul K. Paik; Charles M. Rudin; Andrew Brown; Naiyer A. Rizvi; Naoko Takebe; Wil 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 273 KB

A Phase II Study of Topotecan in Patient

A Phase II Study of Topotecan in Patients with Relapsed Small-Cell Lung Cancer

✍ Koji Takeda; Shunichi Negoro; Toshiyuki Sawa; Kazuhiko Nakagawa; Masaaki Kawahar 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 144 KB

A Phase II Study of Higher Dose Weekly T

A Phase II Study of Higher Dose Weekly Topotecan in Relapsed Small-Cell Lung Cancer

✍ David R. Spigel; F. Anthony Greco; Howard A. Burris III; Dianna L. Shipley; Bobb 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 318 KB

Phase II Study of Obatoclax Mesylate (GX

Phase II Study of Obatoclax Mesylate (GX15-070), a Small-Molecule BCL-2 Family Antagonist, for Patients With Myelofibrosis

✍ Sameer A. Parikh; Hagop Kantarjian; Aaron Schimmer; William Walsh; Ekatherine As 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 121 KB

126 Evaluation of topotecan (Hycamtin™)

126 Evaluation of topotecan (Hycamtin™) in relapsed small cell lung cancer (SCLC). A multicentre phase II study

✍ Depierre, A.; von Pawel, J.; Hans, K.; Moro, D.; Clark, P.; Gatzemeier, U.; Pail 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Randomized phase II study of carboplatin

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer

✍ Langer, Corey J.; Albert, Istvan; Ross, Helen J.; Kovacs, Peter; Blakely, L. Joh 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 689 KB